Oceania Healthcare AI Stock Analysis
Want to see NZ:OCA full AI Analyst Report?
Oceania Healthcare (OCA) AI Stock Analysis
Oceania Healthcare
(NZX:OCA)
The score is held back primarily by the sharp recent earnings and revenue deterioration and a weak technical trend (price below key moving averages with negative MACD). These are partially offset by strong recent operating and free cash flow and an improving leverage profile, but valuation metrics are a major drag due to the extremely high P/E and no provided dividend yield.
Oceania Healthcare (OCA) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- NZD 358.49M
- Dividend Yield
- ―
- Average Volume (3M)
- 541.22K
- Price to Earnings (P/E)
- -63.4
- Beta (1Y)
- 0.95
- Revenue Growth
- 1.25%
- EPS Growth
- -117.68%
- Country
- NZ
- Employees
- 2,246
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Oceania Healthcare Business Overview & Revenue Model
Company Description
Oceania Healthcare Limited, headquartered in Auckland, New Zealand, owns and operates a network of retirement villages and aged care facilities across the country. The company's business activities are categorized into three primary segments: Care Op...
How the Company Makes Money
Oceania’s revenue is primarily generated from (1) its retirement village operations and (2) its aged care operations. In retirement villages, it earns income from selling occupation rights to independent living units (commonly structured in New Zeala...
Oceania Healthcare Financial Statement Overview
Summary
Mixed fundamentals: cash flow is strong (2026 operating cash flow ~$158M and free cash flow ~$140M) and leverage has improved (debt-to-equity down to ~0.45 in 2026). However, the latest year shows clear deterioration in operating results with revenue down ~18.6% YoY and profitability near break-even with very low margins, materially weighing on the score.
Income Statement
42NeutralBalance Sheet
63PositiveCash Flow
74Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 330.73M | 267.14M | 260.57M | 265.46M | 247.18M | 231.14M |
| Gross Profit | 2.48M | 45.03M | 260.57M | 265.46M | 46.51M | 38.61M |
| EBITDA | -5.88M | 4.00M | 68.05M | 63.35M | 53.36M | 89.01M |
| Net Income | -11.67M | 119.00K | 30.41M | 31.47M | 15.45M | 61.13M |
Balance Sheet | ||||||
| Total Assets | 3.13B | 3.08B | 2.94B | 2.78B | 2.54B | 2.20B |
| Cash, Cash Equivalents and Short-Term Investments | 8.23M | 16.59M | 7.59M | 7.49M | 7.44M | 9.74M |
| Total Debt | 0 | 526.81M | 638.31M | 651.72M | 558.39M | 390.03M |
| Total Liabilities | 1.95B | 1.90B | 1.84B | 1.76B | 1.58B | 1.25B |
| Stockholders Equity | 1.18B | 1.18B | 1.10B | 1.03B | 962.26M | 948.84M |
Cash Flow | ||||||
| Free Cash Flow | 156.32M | 140.01M | 70.47M | 33.36M | 15.05M | 49.24M |
| Operating Cash Flow | 177.79M | 157.80M | 110.28M | 85.37M | 70.21M | 105.53M |
| Investing Cash Flow | -12.28M | -33.42M | -100.31M | -161.25M | -219.60M | -218.82M |
| Financing Cash Flow | -161.92M | -115.38M | -9.86M | 75.92M | 147.09M | 43.13M |
Oceania Healthcare Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:OCA, the sentiment is Negative. The current price of 0.59 is below the 20-day moving average (MA) of 0.64, below the 50-day MA of 0.68, and below the 200-day MA of 0.74, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 28.54 is Positive, neither overbought nor oversold. The STOCH value of 6.06 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NZ:OCA.
Oceania Healthcare Peers Comparison
Overall Rating
NZ:TAH70Outperform
NZ:SUM67Neutral
NZ:PHL63Neutral
NZ:RAD56Neutral
NZ:RYM56Neutral
NZ:OCA50Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Outperform | NZD 37.83M | 11.70 | ― | 4.15% | 21.56% | 18.96% | |
| 67Neutral | NZD 1.46B | 4.59 | 8.89% | 2.94% | 14.09% | -18.30% | |
| 63Neutral | NZD 33.62M | 0.03 | ― | ― | 15.19% | 1154.17% | |
| 56Neutral | NZD 113.39M | 10.18 | ― | 6.03% | 9.76% | -1.75% | |
| 56Neutral | NZD 1.91B | -11.12 | -4.17% | ― | 11.86% | 72.99% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 50Neutral | NZD 449.02M | -63.44 | -0.57% | ― | 1.25% | -117.68% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| NZ:OCA | Oceania Healthcare Ltd. | 0.59 | -0.22 | -27.16% | |
| NZ:RYM | Ryman Healthcare | 1.83 | -1.06 | -36.66% | |
| NZ:SUM | Summerset Group Holdings Limited | 5.79 | -6.60 | -53.27% | |
| NZ:PHL | Promisia Healthcare Limited | 0.62 | 0.06 | 11.71% | |
| NZ:TAH | Third Age Health Services Limited | 3.86 | -1.74 | -31.12% | |
| NZ:RAD | Radius Residential Care Ltd | 0.40 | 0.02 | 4.99% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 05, 2026
